Blackstone’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$620K Buy
8,268
+1,868
+29% +$120K ﹤0.01% 320
2026
Q1
$361K Buy
+6,400
New +$417K ﹤0.01% 327

Other funds holding HAE

Blackstone's HAE Position: Q2 2026 in Review

Blackstone increased its Haemonetics (HAE) stake by 29% in Q2 2026, buying an estimated $120K and bringing the position to 8,268 shares worth $620K. The position accounts for ﹤0.01% of the portfolio, ranked #320.

Blackstone first reported a position in HAE in Q1 2026 and has held it in 2 quarters since. 332 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Blackstone held 8,268 shares of Haemonetics worth $620K as of Q2 2026.
  • Blackstone bought 1,868 Haemonetics shares in Q2 2026, an estimated $120K.
  • Haemonetics made up ﹤0.01% of Blackstone's portfolio in Q2 2026, its #320 holding.
  • Blackstone first reported a position in Haemonetics in Q1 2026 and has held it in 2 quarters since.
  • 332 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.